Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosides. (Q54144813)

25 May 2018

title

Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosides. (English)

1 reference

25 May 2018

0 references

McLaurin J

1

1 reference

25 May 2018

Franklin T

series ordinal

2

1 reference

25 May 2018

Fraser PE

series ordinal

3

1 reference

25 May 2018

Chakrabartty A

series ordinal

4

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 February 1998

1 reference

25 May 2018

Journal of Biological Chemistry

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 May 2018

volume

273

1 reference

25 May 2018

issue

8

1 reference

25 May 2018

page(s)

4506-4515

1 reference

25 May 2018

The molecular pathology of Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Cleavage of amyloid beta peptide during constitutive processing of its precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Two conformational states of amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

The complex of microglial cells and amyloid star in three-dimensional reconstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Cell surface extensions associated with overexpression of Alzheimer beta/A4 amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Membrane surface ruffling in cells that over-express Alzheimer amyloid beta/A4 C-terminal peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

The interaction between Alzheimer amyloid beta(1-40) peptide and ganglioside GM1-containing membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Effect of gangliosides on membrane permeability studied by enzymic and fluorescence-spectroscopy techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

The actions of melittin on membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

beta-Amyloid peptide decreases membrane fluidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Calcium-ganglioside interactions and synaptic plasticity: effect of calcium on specific ganglioside/peptide (valinomycin, gramicidin A)-complexes in mixed mono- and bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Alzheimer's disease: genotypes, phenotypes, and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.8.4506

21 January 2018

Identifiers

DOI

10.1074/JBC.273.8.4506

1 reference

25 May 2018

1 reference

25 May 2018